Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc. Common Stock AMIX Peers
See (AMIX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMIX | $1.59 | +27.20% | 5.6M | -0.31 | -$6.46 | N/A |
| ABT | $135.55 | +1.40% | 233.7B | 17.47 | $7.69 | +1.71% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $106.39 | +1.73% | 157.7B | 77.79 | $1.37 | N/A |
| SYK | $392.92 | +0.65% | 150.4B | 53.26 | $7.39 | +0.84% |
| MDT | $87.08 | +1.04% | 110.2B | 23.84 | $3.61 | +3.28% |
| EW | $77.95 | +1.04% | 45.9B | 32.33 | $2.42 | N/A |
| DXCM | $86.35 | +1.54% | 33.9B | 64.91 | $1.33 | N/A |
| STE | $239.40 | +0.36% | 23.5B | 38.72 | $6.17 | +0.96% |
| PHG | $23.92 | -0.69% | 22.3B | 80.47 | $0.30 | +3.68% |
Stock Comparison
AMIX vs ABT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ABT has a market cap of 233.7B. Regarding current trading prices, AMIX is priced at $1.59, while ABT trades at $135.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ABT's P/E ratio is 17.47. In terms of profitability, AMIX's ROE is -1.78%, compared to ABT's ROE of +0.31%. Regarding short-term risk, AMIX is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BSX-PA Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, AMIX is priced at $1.59, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AMIX's ROE is -1.78%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, AMIX is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BSX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BSX has a market cap of 157.7B. Regarding current trading prices, AMIX is priced at $1.59, while BSX trades at $106.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BSX's P/E ratio is 77.79. In terms of profitability, AMIX's ROE is -1.78%, compared to BSX's ROE of +0.10%. Regarding short-term risk, AMIX is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SYK Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SYK has a market cap of 150.4B. Regarding current trading prices, AMIX is priced at $1.59, while SYK trades at $392.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SYK's P/E ratio is 53.26. In terms of profitability, AMIX's ROE is -1.78%, compared to SYK's ROE of +0.11%. Regarding short-term risk, AMIX is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs MDT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, MDT has a market cap of 110.2B. Regarding current trading prices, AMIX is priced at $1.59, while MDT trades at $87.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas MDT's P/E ratio is 23.84. In terms of profitability, AMIX's ROE is -1.78%, compared to MDT's ROE of +0.10%. Regarding short-term risk, AMIX is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs EW Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, EW has a market cap of 45.9B. Regarding current trading prices, AMIX is priced at $1.59, while EW trades at $77.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas EW's P/E ratio is 32.33. In terms of profitability, AMIX's ROE is -1.78%, compared to EW's ROE of +0.49%. Regarding short-term risk, AMIX is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs DXCM Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, DXCM has a market cap of 33.9B. Regarding current trading prices, AMIX is priced at $1.59, while DXCM trades at $86.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas DXCM's P/E ratio is 64.91. In terms of profitability, AMIX's ROE is -1.78%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, AMIX is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs STE Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, STE has a market cap of 23.5B. Regarding current trading prices, AMIX is priced at $1.59, while STE trades at $239.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas STE's P/E ratio is 38.72. In terms of profitability, AMIX's ROE is -1.78%, compared to STE's ROE of +0.09%. Regarding short-term risk, AMIX is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PHG Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PHG has a market cap of 22.3B. Regarding current trading prices, AMIX is priced at $1.59, while PHG trades at $23.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PHG's P/E ratio is 80.47. In terms of profitability, AMIX's ROE is -1.78%, compared to PHG's ROE of +0.03%. Regarding short-term risk, AMIX is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PODD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PODD has a market cap of 22B. Regarding current trading prices, AMIX is priced at $1.59, while PODD trades at $313.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PODD's P/E ratio is 56.41. In terms of profitability, AMIX's ROE is -1.78%, compared to PODD's ROE of +0.35%. Regarding short-term risk, AMIX is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ZBH Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ZBH has a market cap of 18.1B. Regarding current trading prices, AMIX is priced at $1.59, while ZBH trades at $90.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ZBH's P/E ratio is 20.30. In terms of profitability, AMIX's ROE is -1.78%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, AMIX is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ABMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, AMIX is priced at $1.59, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AMIX's ROE is -1.78%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AMIX is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ALGN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ALGN has a market cap of 13.7B. Regarding current trading prices, AMIX is priced at $1.59, while ALGN trades at $190.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ALGN's P/E ratio is 34.21. In terms of profitability, AMIX's ROE is -1.78%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, AMIX is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SNN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SNN has a market cap of 13.2B. Regarding current trading prices, AMIX is priced at $1.59, while SNN trades at $30.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SNN's P/E ratio is 32.14. In terms of profitability, AMIX's ROE is -1.78%, compared to SNN's ROE of +0.08%. Regarding short-term risk, AMIX is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SWAV Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, AMIX is priced at $1.59, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AMIX's ROE is -1.78%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, AMIX is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PEN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PEN has a market cap of 9.9B. Regarding current trading prices, AMIX is priced at $1.59, while PEN trades at $254.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PEN's P/E ratio is 237.06. In terms of profitability, AMIX's ROE is -1.78%, compared to PEN's ROE of +0.04%. Regarding short-term risk, AMIX is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs GMED Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, GMED has a market cap of 7.9B. Regarding current trading prices, AMIX is priced at $1.59, while GMED trades at $58.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas GMED's P/E ratio is 43.72. In terms of profitability, AMIX's ROE is -1.78%, compared to GMED's ROE of +0.05%. Regarding short-term risk, AMIX is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BIO-B Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BIO-B has a market cap of 6.8B. Regarding current trading prices, AMIX is priced at $1.59, while BIO-B trades at $250.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, AMIX's ROE is -1.78%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, AMIX is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BIO Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BIO has a market cap of 6.6B. Regarding current trading prices, AMIX is priced at $1.59, while BIO trades at $244.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BIO's P/E ratio is -3.19. In terms of profitability, AMIX's ROE is -1.78%, compared to BIO's ROE of -0.32%. Regarding short-term risk, AMIX is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BRKR Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BRKR has a market cap of 6.3B. Regarding current trading prices, AMIX is priced at $1.59, while BRKR trades at $41.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BRKR's P/E ratio is 80.38. In terms of profitability, AMIX's ROE is -1.78%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, AMIX is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs GKOS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, GKOS has a market cap of 5.8B. Regarding current trading prices, AMIX is priced at $1.59, while GKOS trades at $103.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas GKOS's P/E ratio is -44.72. In terms of profitability, AMIX's ROE is -1.78%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, AMIX is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs IRTC Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, IRTC has a market cap of 4.9B. Regarding current trading prices, AMIX is priced at $1.59, while IRTC trades at $155.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas IRTC's P/E ratio is -49.59. In terms of profitability, AMIX's ROE is -1.78%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, AMIX is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs NARI Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, AMIX is priced at $1.59, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas NARI's P/E ratio is -59.24. In terms of profitability, AMIX's ROE is -1.78%, compared to NARI's ROE of -0.18%. Regarding short-term risk, AMIX is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs TMDX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, TMDX has a market cap of 4.4B. Regarding current trading prices, AMIX is priced at $1.59, while TMDX trades at $134.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas TMDX's P/E ratio is 92.57. In terms of profitability, AMIX's ROE is -1.78%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, AMIX is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ITGR Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, AMIX is priced at $1.59, while ITGR trades at $122.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ITGR's P/E ratio is 57.29. In terms of profitability, AMIX's ROE is -1.78%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, AMIX is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs INSP Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, INSP has a market cap of 3.9B. Regarding current trading prices, AMIX is priced at $1.59, while INSP trades at $128.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas INSP's P/E ratio is 60.39. In terms of profitability, AMIX's ROE is -1.78%, compared to INSP's ROE of +0.10%. Regarding short-term risk, AMIX is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs AXNX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, AMIX is priced at $1.59, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas AXNX's P/E ratio is -709.80. In terms of profitability, AMIX's ROE is -1.78%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, AMIX is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PRCT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PRCT has a market cap of 3.1B. Regarding current trading prices, AMIX is priced at $1.59, while PRCT trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PRCT's P/E ratio is -33.67. In terms of profitability, AMIX's ROE is -1.78%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, AMIX is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs LIVN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, LIVN has a market cap of 2.5B. Regarding current trading prices, AMIX is priced at $1.59, while LIVN trades at $44.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas LIVN's P/E ratio is -11.24. In terms of profitability, AMIX's ROE is -1.78%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, AMIX is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs NUVA Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, AMIX is priced at $1.59, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AMIX's ROE is -1.78%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AMIX is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs UFPT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, AMIX is priced at $1.59, while UFPT trades at $240.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas UFPT's P/E ratio is 30.02. In terms of profitability, AMIX's ROE is -1.78%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, AMIX is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ATEC Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, AMIX is priced at $1.59, while ATEC trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ATEC's P/E ratio is -9.72. In terms of profitability, AMIX's ROE is -1.78%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, AMIX is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CNMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CNMD has a market cap of 1.6B. Regarding current trading prices, AMIX is priced at $1.59, while CNMD trades at $52.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CNMD's P/E ratio is 13.69. In terms of profitability, AMIX's ROE is -1.78%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, AMIX is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs AORT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, AMIX is priced at $1.59, while AORT trades at $31.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas AORT's P/E ratio is -61.10. In terms of profitability, AMIX's ROE is -1.78%, compared to AORT's ROE of -0.07%. Regarding short-term risk, AMIX is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs HSKA Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, AMIX is priced at $1.59, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AMIX's ROE is -1.78%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AMIX is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs AHCO Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, AMIX is priced at $1.59, while AHCO trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas AHCO's P/E ratio is 16.47. In terms of profitability, AMIX's ROE is -1.78%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, AMIX is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs TNDM Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, AMIX is priced at $1.59, while TNDM trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas TNDM's P/E ratio is -6.79. In terms of profitability, AMIX's ROE is -1.78%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, AMIX is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ESTA Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ESTA has a market cap of 1.2B. Regarding current trading prices, AMIX is priced at $1.59, while ESTA trades at $42.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ESTA's P/E ratio is -13.12. In terms of profitability, AMIX's ROE is -1.78%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, AMIX is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SSII Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SSII has a market cap of 1.1B. Regarding current trading prices, AMIX is priced at $1.59, while SSII trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SSII's P/E ratio is -72.12. In terms of profitability, AMIX's ROE is -1.78%, compared to SSII's ROE of -1.33%. Regarding short-term risk, AMIX is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SILK Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, AMIX is priced at $1.59, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SILK's P/E ratio is -18.96. In terms of profitability, AMIX's ROE is -1.78%, compared to SILK's ROE of -0.29%. Regarding short-term risk, AMIX is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs FNA Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, AMIX is priced at $1.59, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas FNA's P/E ratio is -19.83. In terms of profitability, AMIX's ROE is -1.78%, compared to FNA's ROE of -0.36%. Regarding short-term risk, AMIX is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs INMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, INMD has a market cap of 987M. Regarding current trading prices, AMIX is priced at $1.59, while INMD trades at $14.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas INMD's P/E ratio is 6.36. In terms of profitability, AMIX's ROE is -1.78%, compared to INMD's ROE of +0.25%. Regarding short-term risk, AMIX is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs IART Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, IART has a market cap of 955.1M. Regarding current trading prices, AMIX is priced at $1.59, while IART trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas IART's P/E ratio is -32.34. In terms of profitability, AMIX's ROE is -1.78%, compared to IART's ROE of -0.03%. Regarding short-term risk, AMIX is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CSII Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, AMIX is priced at $1.59, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CSII's P/E ratio is -20.83. In terms of profitability, AMIX's ROE is -1.78%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AMIX is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SIBN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SIBN has a market cap of 785.4M. Regarding current trading prices, AMIX is priced at $1.59, while SIBN trades at $18.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SIBN's P/E ratio is -29.25. In terms of profitability, AMIX's ROE is -1.78%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, AMIX is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs IRMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, IRMD has a market cap of 773.6M. Regarding current trading prices, AMIX is priced at $1.59, while IRMD trades at $60.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas IRMD's P/E ratio is 39.25. In terms of profitability, AMIX's ROE is -1.78%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, AMIX is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CRY Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, AMIX is priced at $1.59, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CRY's P/E ratio is 425.71. In terms of profitability, AMIX's ROE is -1.78%, compared to CRY's ROE of -0.07%. Regarding short-term risk, AMIX is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CBLL Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CBLL has a market cap of 683.1M. Regarding current trading prices, AMIX is priced at $1.59, while CBLL trades at $19.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CBLL's P/E ratio is -15.12. In terms of profitability, AMIX's ROE is -1.78%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, AMIX is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BFLY-WT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BFLY-WT has a market cap of 602.1M. Regarding current trading prices, AMIX is priced at $1.59, while BFLY-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, AMIX's ROE is -1.78%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, AMIX is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for AMIX.
AMIX vs APEN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, AMIX is priced at $1.59, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas APEN's P/E ratio is -9.43. In terms of profitability, AMIX's ROE is -1.78%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AMIX is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs AVNS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, AVNS has a market cap of 565.6M. Regarding current trading prices, AMIX is priced at $1.59, while AVNS trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas AVNS's P/E ratio is -1.48. In terms of profitability, AMIX's ROE is -1.78%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, AMIX is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs KIDS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, KIDS has a market cap of 529.3M. Regarding current trading prices, AMIX is priced at $1.59, while KIDS trades at $21.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas KIDS's P/E ratio is -12.14. In terms of profitability, AMIX's ROE is -1.78%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, AMIX is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs RXST Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, RXST has a market cap of 514.9M. Regarding current trading prices, AMIX is priced at $1.59, while RXST trades at $12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas RXST's P/E ratio is -19.20. In terms of profitability, AMIX's ROE is -1.78%, compared to RXST's ROE of -0.10%. Regarding short-term risk, AMIX is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BFLY Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BFLY has a market cap of 484.7M. Regarding current trading prices, AMIX is priced at $1.59, while BFLY trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BFLY's P/E ratio is -6.53. In terms of profitability, AMIX's ROE is -1.78%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, AMIX is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs AXGN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, AXGN has a market cap of 478.2M. Regarding current trading prices, AMIX is priced at $1.59, while AXGN trades at $10.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas AXGN's P/E ratio is -65.62. In terms of profitability, AMIX's ROE is -1.78%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, AMIX is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CTKB Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CTKB has a market cap of 449.6M. Regarding current trading prices, AMIX is priced at $1.59, while CTKB trades at $3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CTKB's P/E ratio is -39.44. In terms of profitability, AMIX's ROE is -1.78%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, AMIX is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BVS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BVS has a market cap of 449.2M. Regarding current trading prices, AMIX is priced at $1.59, while BVS trades at $6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BVS's P/E ratio is -14.10. In terms of profitability, AMIX's ROE is -1.78%, compared to BVS's ROE of -0.21%. Regarding short-term risk, AMIX is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs OFIX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, OFIX has a market cap of 434.5M. Regarding current trading prices, AMIX is priced at $1.59, while OFIX trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas OFIX's P/E ratio is -3.00. In terms of profitability, AMIX's ROE is -1.78%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, AMIX is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SMLR Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SMLR has a market cap of 429.3M. Regarding current trading prices, AMIX is priced at $1.59, while SMLR trades at $38.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SMLR's P/E ratio is -16.11. In terms of profitability, AMIX's ROE is -1.78%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, AMIX is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SRDX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SRDX has a market cap of 412M. Regarding current trading prices, AMIX is priced at $1.59, while SRDX trades at $29.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SRDX's P/E ratio is -20.58. In terms of profitability, AMIX's ROE is -1.78%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, AMIX is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PACB Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PACB has a market cap of 387.1M. Regarding current trading prices, AMIX is priced at $1.59, while PACB trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PACB's P/E ratio is -0.47. In terms of profitability, AMIX's ROE is -1.78%, compared to PACB's ROE of -1.70%. Regarding short-term risk, AMIX is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SENS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SENS has a market cap of 372.5M. Regarding current trading prices, AMIX is priced at $1.59, while SENS trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SENS's P/E ratio is -4.49. In terms of profitability, AMIX's ROE is -1.78%, compared to SENS's ROE of -7.46%. Regarding short-term risk, AMIX is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs TMCI Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, TMCI has a market cap of 361.7M. Regarding current trading prices, AMIX is priced at $1.59, while TMCI trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas TMCI's P/E ratio is -6.76. In terms of profitability, AMIX's ROE is -1.78%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, AMIX is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs VREX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, VREX has a market cap of 356.1M. Regarding current trading prices, AMIX is priced at $1.59, while VREX trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas VREX's P/E ratio is -8.33. In terms of profitability, AMIX's ROE is -1.78%, compared to VREX's ROE of -0.08%. Regarding short-term risk, AMIX is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs NPCE Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, NPCE has a market cap of 351.3M. Regarding current trading prices, AMIX is priced at $1.59, while NPCE trades at $11.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas NPCE's P/E ratio is -13.06. In terms of profitability, AMIX's ROE is -1.78%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, AMIX is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs OM Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, OM has a market cap of 338M. Regarding current trading prices, AMIX is priced at $1.59, while OM trades at $19.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas OM's P/E ratio is -0.66. In terms of profitability, AMIX's ROE is -1.78%, compared to OM's ROE of -1.45%. Regarding short-term risk, AMIX is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CLPT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CLPT has a market cap of 333.5M. Regarding current trading prices, AMIX is priced at $1.59, while CLPT trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CLPT's P/E ratio is -15.53. In terms of profitability, AMIX's ROE is -1.78%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, AMIX is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs NNOX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, NNOX has a market cap of 333.5M. Regarding current trading prices, AMIX is priced at $1.59, while NNOX trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas NNOX's P/E ratio is -5.75. In terms of profitability, AMIX's ROE is -1.78%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, AMIX is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CATX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CATX has a market cap of 278.4M. Regarding current trading prices, AMIX is priced at $1.59, while CATX trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CATX's P/E ratio is -3.05. In terms of profitability, AMIX's ROE is -1.78%, compared to CATX's ROE of -0.27%. Regarding short-term risk, AMIX is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs VMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, VMD has a market cap of 273.5M. Regarding current trading prices, AMIX is priced at $1.59, while VMD trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas VMD's P/E ratio is 23.07. In terms of profitability, AMIX's ROE is -1.78%, compared to VMD's ROE of +0.10%. Regarding short-term risk, AMIX is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CERS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CERS has a market cap of 271.4M. Regarding current trading prices, AMIX is priced at $1.59, while CERS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CERS's P/E ratio is -14.20. In terms of profitability, AMIX's ROE is -1.78%, compared to CERS's ROE of -0.35%. Regarding short-term risk, AMIX is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PTHL Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PTHL has a market cap of 259.9M. Regarding current trading prices, AMIX is priced at $1.59, while PTHL trades at $17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PTHL's P/E ratio is -364.80. In terms of profitability, AMIX's ROE is -1.78%, compared to PTHL's ROE of -0.30%. Regarding short-term risk, AMIX is more volatile compared to PTHL. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ZIMV Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ZIMV has a market cap of 258.6M. Regarding current trading prices, AMIX is priced at $1.59, while ZIMV trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ZIMV's P/E ratio is -10.29. In terms of profitability, AMIX's ROE is -1.78%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, AMIX is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs QTRX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, QTRX has a market cap of 258.4M. Regarding current trading prices, AMIX is priced at $1.59, while QTRX trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas QTRX's P/E ratio is -5.36. In terms of profitability, AMIX's ROE is -1.78%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, AMIX is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SNWV Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SNWV has a market cap of 256.2M. Regarding current trading prices, AMIX is priced at $1.59, while SNWV trades at $31.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SNWV's P/E ratio is -4.81. In terms of profitability, AMIX's ROE is -1.78%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, AMIX is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BWAY Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BWAY has a market cap of 249.8M. Regarding current trading prices, AMIX is priced at $1.59, while BWAY trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BWAY's P/E ratio is 60.09. In terms of profitability, AMIX's ROE is -1.78%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, AMIX is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs MASS Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, MASS has a market cap of 241.3M. Regarding current trading prices, AMIX is priced at $1.59, while MASS trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas MASS's P/E ratio is -3.03. In terms of profitability, AMIX's ROE is -1.78%, compared to MASS's ROE of -0.13%. Regarding short-term risk, AMIX is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs TCMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, TCMD has a market cap of 240.4M. Regarding current trading prices, AMIX is priced at $1.59, while TCMD trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas TCMD's P/E ratio is 15.67. In terms of profitability, AMIX's ROE is -1.78%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, AMIX is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs MXCT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, MXCT has a market cap of 233.9M. Regarding current trading prices, AMIX is priced at $1.59, while MXCT trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas MXCT's P/E ratio is -5.50. In terms of profitability, AMIX's ROE is -1.78%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, AMIX is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs NVRO Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, AMIX is priced at $1.59, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AMIX's ROE is -1.78%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AMIX is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs SGHT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, SGHT has a market cap of 222.3M. Regarding current trading prices, AMIX is priced at $1.59, while SGHT trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas SGHT's P/E ratio is -4.39. In terms of profitability, AMIX's ROE is -1.78%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, AMIX is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs EYES Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, AMIX is priced at $1.59, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas EYES's P/E ratio is N/A. In terms of profitability, AMIX's ROE is -1.78%, compared to EYES's ROE of -0.26%. Regarding short-term risk, AMIX is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BSGM Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BSGM has a market cap of 208.5M. Regarding current trading prices, AMIX is priced at $1.59, while BSGM trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BSGM's P/E ratio is -14.42. In terms of profitability, AMIX's ROE is -1.78%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, AMIX is more volatile compared to BSGM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs TLSI Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, TLSI has a market cap of 202M. Regarding current trading prices, AMIX is priced at $1.59, while TLSI trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas TLSI's P/E ratio is -4.84. In terms of profitability, AMIX's ROE is -1.78%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, AMIX is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs INGN Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, INGN has a market cap of 190.4M. Regarding current trading prices, AMIX is priced at $1.59, while INGN trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas INGN's P/E ratio is -6.16. In terms of profitability, AMIX's ROE is -1.78%, compared to INGN's ROE of -0.15%. Regarding short-term risk, AMIX is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ELMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ELMD has a market cap of 184.1M. Regarding current trading prices, AMIX is priced at $1.59, while ELMD trades at $21.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ELMD's P/E ratio is 27.78. In terms of profitability, AMIX's ROE is -1.78%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, AMIX is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs PROF Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, PROF has a market cap of 180.3M. Regarding current trading prices, AMIX is priced at $1.59, while PROF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas PROF's P/E ratio is -4.96. In terms of profitability, AMIX's ROE is -1.78%, compared to PROF's ROE of -0.70%. Regarding short-term risk, AMIX is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs RPID Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, RPID has a market cap of 156.9M. Regarding current trading prices, AMIX is priced at $1.59, while RPID trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas RPID's P/E ratio is -3.48. In terms of profitability, AMIX's ROE is -1.78%, compared to RPID's ROE of -0.56%. Regarding short-term risk, AMIX is more volatile compared to RPID. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ANIK Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ANIK has a market cap of 154M. Regarding current trading prices, AMIX is priced at $1.59, while ANIK trades at $10.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ANIK's P/E ratio is -14.32. In terms of profitability, AMIX's ROE is -1.78%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, AMIX is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs LNSR Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, LNSR has a market cap of 151.9M. Regarding current trading prices, AMIX is priced at $1.59, while LNSR trades at $12.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas LNSR's P/E ratio is -2.63. In terms of profitability, AMIX's ROE is -1.78%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, AMIX is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs CVRX Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, CVRX has a market cap of 151.7M. Regarding current trading prices, AMIX is priced at $1.59, while CVRX trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas CVRX's P/E ratio is -2.72. In terms of profitability, AMIX's ROE is -1.78%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, AMIX is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs AVR Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, AVR has a market cap of 151.4M. Regarding current trading prices, AMIX is priced at $1.59, while AVR trades at $3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas AVR's P/E ratio is -1.17. In terms of profitability, AMIX's ROE is -1.78%, compared to AVR's ROE of -2.92%. Regarding short-term risk, AMIX is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs RCEL Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, RCEL has a market cap of 144.1M. Regarding current trading prices, AMIX is priced at $1.59, while RCEL trades at $5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas RCEL's P/E ratio is -2.49. In terms of profitability, AMIX's ROE is -1.78%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, AMIX is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs BDMD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, BDMD has a market cap of 139.3M. Regarding current trading prices, AMIX is priced at $1.59, while BDMD trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas BDMD's P/E ratio is 7.96. In terms of profitability, AMIX's ROE is -1.78%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, AMIX is less volatile compared to BDMD. This indicates potentially lower risk in terms of short-term price fluctuations for AMIX.
AMIX vs OWLT Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, OWLT has a market cap of 130.9M. Regarding current trading prices, AMIX is priced at $1.59, while OWLT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas OWLT's P/E ratio is -4.92. In terms of profitability, AMIX's ROE is -1.78%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, AMIX is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs LUCD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, LUCD has a market cap of 126.6M. Regarding current trading prices, AMIX is priced at $1.59, while LUCD trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas LUCD's P/E ratio is -1.00. In terms of profitability, AMIX's ROE is -1.78%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, AMIX is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs ICAD Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, ICAD has a market cap of 105.2M. Regarding current trading prices, AMIX is priced at $1.59, while ICAD trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas ICAD's P/E ratio is -20.16. In terms of profitability, AMIX's ROE is -1.78%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, AMIX is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs LUNG Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, LUNG has a market cap of 104.7M. Regarding current trading prices, AMIX is priced at $1.59, while LUNG trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas LUNG's P/E ratio is -1.81. In terms of profitability, AMIX's ROE is -1.78%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, AMIX is more volatile compared to LUNG. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.
AMIX vs MGRM Comparison
AMIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIX stands at 5.6M. In comparison, MGRM has a market cap of 103.5M. Regarding current trading prices, AMIX is priced at $1.59, while MGRM trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIX currently has a P/E ratio of -0.31, whereas MGRM's P/E ratio is -5.80. In terms of profitability, AMIX's ROE is -1.78%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, AMIX is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIX.